Read news as it happens
Create a Rediffmail account
Subscribe via RSS
Dr Reddy's diabetic drug shows promising results
The Indian drug industry's dream of coming out with an own new chemical entity or an originally researched new drug has received a big boost. Balaglitazone, the diabetic drug molecule being......
Glenmark may beat rivals in chemical entity sale
Glenmark Pharmaceuticals, India's 11th biggest drug maker by sales, may beat bigger rivals, including Ranbaxy, Dr Reddy's and Nicholas Piramal, in selling an original drug, or novel chemical......
US crisis may hit Indian drug R&D
Stringent regulatory norms and the financial impact of the global credit crisis on some research companies may hurt half a dozen molecules of Indian companies, such as Glenmark, Nicholas Piramal......
Dr Reddy's bets big on drug discovery
Dr Reddy's Laboratories hopes to become a true drug discovery company in the near future, said chairman K Anji Reddy and chief executive officer GV Prasad at the 24th annual general body meeting in......
Dr Reddy's to ramp up spending on R&D
Dr Reddy's Laboratories Limited aims to increase the R&D spend on its three major research programmes, including the reverse cholesterol transport area, in a bid to come out with pathbreaking......
Top Coverage News
World Test Championship 2023
India held the top position in the ICC Men's Test Team Rankings while Australia secured the...
Here are news, updates and coverage from violence hit Manipur.
Complete coverage of IPL 2023
Sri Lanka's Tour of India 2023
Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.
GUJARAT, HIMACHAL GO TO POLLS
The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Office email App
© 2023 Rediff.com